Examples of using Warfarin in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Changing from Lixiana to vitamin K antagonists e.g. warfarin.
Users consuming Warfarin to consult a physician before using this supplement.
To Lixiana Stop taking the vitamin K antagonist e.g. warfarin.
Therefore, when warfarin is co-administered, close INR follow-up and monitoring monitoring is recommended.
Anticoagulation parameters should be monitored when warfarin is coadministered with indinavir/ ritonavir.
In rare cases, Cushing's can cause hypercalcemia,which can lead to the same skin necrosis as warfarin.
However, patients taking warfarin or phenprocoumon should have their INR checked regularly see section 4.4.
Issued a device correction notice for their INR device that is used to monitor INR values in patients using warfarin.
Compared with warfarin, although there may be less difference where warfarin treatment is well managed.
Further episodes were seen in 130 of 4,118 patients given edoxaban(3.2%)and in 146 of 4,122 given warfarin 3.5.
Nevertheless, patients receiving warfarin should be closely monitored when{PRODUCT NAME} is added to their therapy.
Patients were excluded from participation in IMBRUVICA phase 2 and3 studies if they required warfarin or other vitamin K antagonists.
For patients randomised to warfarin, the median percentage of time in therapeutic range(TTR)(INR 2-3) was 66.
In addition, J-ROCKET AF showed a 51% reduction of stroke andnon-CNS systemic embolism in the Xarelto group compared with patients receiving warfarin.
Guidelines for warfarin clearly state that people who take the drug should be cautious regarding the intake ofcranberry, as they are at high risk of bleeding.
After initiation of febuxostat therapy, monitoring of anticoagulant activityshould be considered in patients receiving warfarin or similar agents.
Because of the potential for increased risk of bleeding, warfarin(or other coumarin derivatives) and prasugrel should be co-administered with caution see section 4.4.
In this real-world setting rivaroxaban(n=11,411) was seen to be associated with a non-significant 29% decrease in ischemic stroke accompanied by a significant 47% reduction in ICH vs. warfarin n=11,411.
Pharmacodynamic interactions Patients receiving warfarin or similar anticoagulant agents or acetylsalicylic acid have an increased risk of bleeding complications, when treated with< Nimesulide-containing medicinal products.
If it is desired to test the pharmacodynamic effects of rivaroxaban during the conversion period, anti- factor Xa activity, PiCT, andHeptest can be used as these tests were not affected by warfarin.
After concomitant administration of warfarin 25 mg with repeated dosing of lixisenatide 20 mcg, there were no effects on AUC or INR(International Normalised Ratio) while Cmax was reduced by 19% and tmax was delayed by 7 hours.
The equator following the example of monotherapy with amlodipine can be effectively combined with anesthesia,"loopback" and thiazide diuretics, ACE inhibitors, long-acting nitrates, digoxin, nitroglycerin sublingual,atorvastatin, warfarin, sildenafil.
The primary objective of ROCKET AF was to demonstrate theefficacy of once-daily rivaroxaban in comparison to dose-adjusted warfarin in the prevention of stroke and non-CNS systemic embolism in patients with non-valvular atrial fibrillation.
Known interaction with drugs- according to the federal institute of medicines and medicine products in Germany(BfARM) it is possible that this product interacts with certain blood-thinning drugs(vitamin K antagonists)like Phenprocoumon(Marcumar) and Warfarin Coumadin.
Common blood-thinning medications(i.e., aspirin)as well as anticoagulants taken to prevent blood clots(i.e., Warfarin/Coumadin, Plavix, and Jantoven) can lead to frequent nose bleeds because they impact the body's clotting ability.
However, a majority of herbal medicines do not cause any significant harm or side-effects, and may be used in conjunction with conventional medicines,providing the physician does not outline any specific harmful interactions e.g. warfarin and EGb761. Summary.
The main analysis of efficacy was aimed to show the non-inferiority of edoxaban versus warfarin on first stroke or SEE that occurred during treatment or within 3 days from the last dose taken in the modified intention-to-treat(mITT) population.
Interaction studies conducted in healthy volunteers suggest that the pharmacokinetics of empagliflozin were not influenced by co-administration with metformin, glimepiride, pioglitazone, sitagliptin,linagliptin, warfarin, verapamil, ramipril, simvastatin, torasemide and hydrochlorothiazide.
In clinical studies, lasofoxifene did not alter the metabolism of dextromethorphan(CYP2D6 substrate) and chlorzoxazone(CYP2E1 substrate)or the pharmacokinetics of warfarin(CYP2C9 substrate), methylprednisolone(CYP3A4 substrate) or digoxin MDR1 P-glycoprotein substrate.
